Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies.

JCI insight

Walti CS, Krantz EM, Maalouf J, Boonyaratanakornkit J, Keane-Candib J, Joncas-Schronce L, Stevens-Ayers T, Dasgupta S, Taylor JJ, Hirayama AV, Bar M, Gardner RA, Cowan AJ, Green DJ, Boeckh MJ, Maloney DG, Turtle CJ, Hill JA.
PMID: 33914708
JCI Insight. 2021 Jun 08;6(11). doi: 10.1172/jci.insight.146743.

BACKGROUNDLittle is known about pathogen-specific humoral immunity after chimeric antigen receptor-modified T (CAR-T) cell therapy for B cell malignancies.METHODSWe conducted a prospective cross-sectional study of CD19-targeted or B cell maturation antigen-targeted (BCMA-targeted) CAR-T cell therapy recipients at least 6...

Cite
Walti CS, Krantz EM, Maalouf J, et al. Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies. JCI Insight. 2021;6(11)doi: 10.1172/jci.insight.146743.
Walti, C. S., Krantz, E. M., Maalouf, J., Boonyaratanakornkit, J., Keane-Candib, J., Joncas-Schronce, L., Stevens-Ayers, T., Dasgupta, S., Taylor, J. J., Hirayama, A. V., Bar, M., Gardner, R. A., Cowan, A. J., Green, D. J., Boeckh, M. J., Maloney, D. G., Turtle, C. J., & Hill, J. A. (2021). Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies. JCI insight, 6(11), . https://doi.org/10.1172/jci.insight.146743
Walti, Carla S, et al. "Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies." JCI insight vol. 6,11 (2021). doi: https://doi.org/10.1172/jci.insight.146743
Walti CS, Krantz EM, Maalouf J, Boonyaratanakornkit J, Keane-Candib J, Joncas-Schronce L, Stevens-Ayers T, Dasgupta S, Taylor JJ, Hirayama AV, Bar M, Gardner RA, Cowan AJ, Green DJ, Boeckh MJ, Maloney DG, Turtle CJ, Hill JA. Antibodies against vaccine-preventable infections after CAR-T cell therapy for B cell malignancies. JCI Insight. 2021 Jun 08;6(11). doi: 10.1172/jci.insight.146743. PMID: 33914708; PMCID: PMC8262349.
Copy Download .nbib Format: NLM
Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Hill JA, Dalai SC, Hong DK, Ahmed AA, Ho C, Hollemon D, Blair L, Maalouf J, Keane-Candib J, Stevens-Ayers T, Boeckh M, Blauwkamp TA, Fisher CE.
PMID: 33119063
Clin Infect Dis. 2021 Dec 06;73(11):e3876-e3883. doi: 10.1093/cid/ciaa1639.

BACKGROUND: Noninvasive diagnostic options are limited for invasive mold infections (IMIs). We evaluated the performance of a plasma microbial cell-free DNA sequencing (mcfDNA-Seq) test for diagnosing pulmonary IMI after hematopoietic cell transplant (HCT).METHODS: We retrospectively assessed the diagnostic performance...

Cite
Hill JA, Dalai SC, Hong DK, et al. Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma. Clin Infect Dis. 2021;73(11):e3876-e3883doi: 10.1093/cid/ciaa1639.
Hill, J. A., Dalai, S. C., Hong, D. K., Ahmed, A. A., Ho, C., Hollemon, D., Blair, L., Maalouf, J., Keane-Candib, J., Stevens-Ayers, T., Boeckh, M., Blauwkamp, T. A., & Fisher, C. E. (2021). Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(11), e3876-e3883. https://doi.org/10.1093/cid/ciaa1639
Hill, Joshua A, et al. "Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 73,11 (2021): e3876-e3883. doi: https://doi.org/10.1093/cid/ciaa1639
Hill JA, Dalai SC, Hong DK, Ahmed AA, Ho C, Hollemon D, Blair L, Maalouf J, Keane-Candib J, Stevens-Ayers T, Boeckh M, Blauwkamp TA, Fisher CE. Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma. Clin Infect Dis. 2021 Dec 06;73(11):e3876-e3883. doi: 10.1093/cid/ciaa1639. PMID: 33119063; PMCID: PMC8664431.
Copy Download .nbib Format: NLM
Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Hill JA, Dalai SC, Hong DK, Ahmed AA, Ho C, Hollemon D, Blair L, Maalouf J, Keane-Candib J, Stevens-Ayers T, Boeckh M, Blauwkamp TA, Fisher CE.
PMID: 33119063
Clin Infect Dis. 2021 Dec 06;73(11):e3876-e3883. doi: 10.1093/cid/ciaa1639.

BACKGROUND: Noninvasive diagnostic options are limited for invasive mold infections (IMIs). We evaluated the performance of a plasma microbial cell-free DNA sequencing (mcfDNA-Seq) test for diagnosing pulmonary IMI after hematopoietic cell transplant (HCT).METHODS: We retrospectively assessed the diagnostic performance...

Cite
Hill JA, Dalai SC, Hong DK, et al. Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma. Clin Infect Dis. 2021;73(11):e3876-e3883doi: 10.1093/cid/ciaa1639.
Hill, J. A., Dalai, S. C., Hong, D. K., Ahmed, A. A., Ho, C., Hollemon, D., Blair, L., Maalouf, J., Keane-Candib, J., Stevens-Ayers, T., Boeckh, M., Blauwkamp, T. A., & Fisher, C. E. (2021). Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(11), e3876-e3883. https://doi.org/10.1093/cid/ciaa1639
Hill, Joshua A, et al. "Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 73,11 (2021): e3876-e3883. doi: https://doi.org/10.1093/cid/ciaa1639
Hill JA, Dalai SC, Hong DK, Ahmed AA, Ho C, Hollemon D, Blair L, Maalouf J, Keane-Candib J, Stevens-Ayers T, Boeckh M, Blauwkamp TA, Fisher CE. Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma. Clin Infect Dis. 2021 Dec 06;73(11):e3876-e3883. doi: 10.1093/cid/ciaa1639. PMID: 33119063.
Copy Download .nbib Format: NLM
A MULTICENTER, LONGITUDINAL, INTERVENTIONAL, DOUBLE BLIND RANDOMIZED CLINICAL TRIAL IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RESIDING IN REMOTE AREAS: LESSONS LEARNED FROM THE LATE CYTOMEGALOVIRUS PREVENTION TRIAL.

Contemporary clinical trials communications

Kimball LE, Stevens-Ayers T, Green ML, Xie H, Flowers ME, Jerome KR, LeBlanc R, Dahlgren C, Nichols WG, Chemaly RF, Papanicolaou G, Boeckh M.
PMID: 28184381
Contemp Clin Trials Commun. 2016 Dec 15;4:84-89. doi: 10.1016/j.conctc.2016.05.002. Epub 2016 May 05.

PURPOSE: The logistics of conducting double-blinded phase III clinical trials with participants residing in remote locations are complex. Here we describe the implementation of an interventional trial for the prevention of late cytomegalovirus (CMV) disease in hematopoietic cell transplantation...

Cite
Kimball LE, Stevens-Ayers T, Green ML, et al. A MULTICENTER, LONGITUDINAL, INTERVENTIONAL, DOUBLE BLIND RANDOMIZED CLINICAL TRIAL IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RESIDING IN REMOTE AREAS: LESSONS LEARNED FROM THE LATE CYTOMEGALOVIRUS PREVENTION TRIAL. Contemp Clin Trials Commun. 2016;4:84-89doi: 10.1016/j.conctc.2016.05.002.
Kimball, L. E., Stevens-Ayers, T., Green, M. L., Xie, H., Flowers, M. E., Jerome, K. R., LeBlanc, R., Dahlgren, C., Nichols, W. G., Chemaly, R. F., Papanicolaou, G., & Boeckh, M. (2016). A MULTICENTER, LONGITUDINAL, INTERVENTIONAL, DOUBLE BLIND RANDOMIZED CLINICAL TRIAL IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RESIDING IN REMOTE AREAS: LESSONS LEARNED FROM THE LATE CYTOMEGALOVIRUS PREVENTION TRIAL. Contemporary clinical trials communications, 484-89. https://doi.org/10.1016/j.conctc.2016.05.002
Kimball, Louise E, et al. "A MULTICENTER, LONGITUDINAL, INTERVENTIONAL, DOUBLE BLIND RANDOMIZED CLINICAL TRIAL IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RESIDING IN REMOTE AREAS: LESSONS LEARNED FROM THE LATE CYTOMEGALOVIRUS PREVENTION TRIAL." Contemporary clinical trials communications vol. 4 (2016): 84-89. doi: https://doi.org/10.1016/j.conctc.2016.05.002
Kimball LE, Stevens-Ayers T, Green ML, Xie H, Flowers ME, Jerome KR, LeBlanc R, Dahlgren C, Nichols WG, Chemaly RF, Papanicolaou G, Boeckh M. A MULTICENTER, LONGITUDINAL, INTERVENTIONAL, DOUBLE BLIND RANDOMIZED CLINICAL TRIAL IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RESIDING IN REMOTE AREAS: LESSONS LEARNED FROM THE LATE CYTOMEGALOVIRUS PREVENTION TRIAL. Contemp Clin Trials Commun. 2016 Dec 15;4:84-89. doi: 10.1016/j.conctc.2016.05.002. Epub 2016 May 05. PMID: 28184381; PMCID: PMC5292623.
Copy Download .nbib Format: NLM
Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Hill JA, Dalai SC, Hong DK, Ahmed AA, Ho C, Hollemon D, Blair L, Maalouf J, Keane-Candib J, Stevens-Ayers T, Boeckh M, Blauwkamp TA, Fisher CE.
PMID: 33119063
Clin Infect Dis. 2021 Dec 06;73(11):e3876-e3883. doi: 10.1093/cid/ciaa1639.

BACKGROUND: Noninvasive diagnostic options are limited for invasive mold infections (IMIs). We evaluated the performance of a plasma microbial cell-free DNA sequencing (mcfDNA-Seq) test for diagnosing pulmonary IMI after hematopoietic cell transplant (HCT).METHODS: We retrospectively assessed the diagnostic performance...

Cite
Hill JA, Dalai SC, Hong DK, et al. Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma. Clin Infect Dis. 2021;73(11):e3876-e3883doi: 10.1093/cid/ciaa1639.
Hill, J. A., Dalai, S. C., Hong, D. K., Ahmed, A. A., Ho, C., Hollemon, D., Blair, L., Maalouf, J., Keane-Candib, J., Stevens-Ayers, T., Boeckh, M., Blauwkamp, T. A., & Fisher, C. E. (2021). Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(11), e3876-e3883. https://doi.org/10.1093/cid/ciaa1639
Hill, Joshua A, et al. "Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 73,11 (2021): e3876-e3883. doi: https://doi.org/10.1093/cid/ciaa1639
Hill JA, Dalai SC, Hong DK, Ahmed AA, Ho C, Hollemon D, Blair L, Maalouf J, Keane-Candib J, Stevens-Ayers T, Boeckh M, Blauwkamp TA, Fisher CE. Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in Plasma. Clin Infect Dis. 2021 Dec 06;73(11):e3876-e3883. doi: 10.1093/cid/ciaa1639. PMID: 33119063; PMCID: PMC8664431.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries